Albert J Czaja (A J Czaja)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 22

Top Venues

Alimentary pharmacology & therapeutics

Digestive diseases and sciences

Expert review of clinical immunology

Clinical liver disease

Mayo Clinic College of Medicine and Science

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mayo Clinic College of Medicine and Science Mar 30 2007

United States

Professor Emeritus of Medicine :: Gastroenterology/Hepatology

Mayo Clinic Rochester - Mar 30 2007

United States

Professor of Medicine :: Gastroenterology/Hepatology

Publications

Albert J Czaja
Incorporating the Molecular Mimicry of Environmental Antigens into the Causality of Autoimmune Hepatitis. Digestive diseases and sciences (2023)
Albert J Czaja
Introducing Molecular Chaperones into the Causality and Prospective Management of Autoimmune Hepatitis. Digestive diseases and sciences (2023)
Albert J Czaja
Incorporating the Molecular Mimicry of Environmental Antigens into the Causality of Autoimmune Hepatitis. Digestive diseases and sciences (2023)
Albert J Czaja
Examining micro-ribonucleic acids as diagnostic and therapeutic prospects in autoimmune hepatitis. Expert review of clinical immunology 18 (6) (2022)
Albert J Czaja
Missing Causality and Heritability of Autoimmune Hepatitis. Digestive diseases and sciences (2022)
Albert J Czaja
Advancing Biologic Therapy for Refractory Autoimmune Hepatitis. Digestive diseases and sciences 67 (11) (2022)
Albert J Czaja
Review article: targeting the B cell activation system in autoimmune hepatitis. Alimentary pharmacology & therapeutics 54 (7) (2021)
Albert J Czaja
Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis. Digestive diseases and sciences (2021)
Maryam Ebadi, Albert J Czaja, Aldo J Montano-Loza
Letter: severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis-offender or bystander? Authors' reply. Alimentary pharmacology & therapeutics 49 (7) (2020)
Maryam Ebadi, Albert J Czaja, Aldo J Montano-Loza
Letter: vitamin D deficiency and autoimmune hepatitis - from research to treatment-authors' reply. Alimentary pharmacology & therapeutics 49 (8) (2020)
Albert J Czaja
Letter: high ferritin to haemoglobin ratio is related to early mortality in patients with alcoholic hepatitis - author's reply. Alimentary pharmacology & therapeutics 49 (11) (2020)
Albert J Czaja
Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis. Alimentary pharmacology & therapeutics 51 (12) (2020)
Albert J Czaja
Editorial: tailoring mycophenolate mofetil rescue therapy for success in autoimmune hepatitis. Alimentary pharmacology & therapeutics 49 (11) (2020)
Albert J Czaja
Autoimmune Hepatitis: Surviving Crises of Doubt and Elimination. Clinical liver disease 15 (Suppl 1) (2020)
Albert J Czaja
Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis. Digestive diseases and sciences 66 (8) (2020)
Maryam Ebadi, Albert J Czaja, Aldo J Montano-Loza
Editorial: the role of vitamin D in autoimmune hepatitis-authors' reply. Alimentary pharmacology & therapeutics 49 (3) (2019)
Albert J Czaja
Review article: iron disturbances in chronic liver diseases other than haemochromatosis - pathogenic, prognostic, and therapeutic implications. Alimentary pharmacology & therapeutics 49 (6) (2019)
Albert J Czaja
Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis. Autoimmunity 52 (4) (2019)
Albert J Czaja
Epigenetic changes and their implications in autoimmune hepatitis. European journal of clinical investigation 48 (4) (2018)
Albert J Czaja
Emerging therapeutic biomarkers of autoimmune hepatitis and their impact on current and future management. Expert review of gastroenterology & hepatology 12 (6) (2018)
Maryam Ebadi, Rahima A Bhanji, Vera C Mazurak, Ellina Lytvyak, Andrew L Mason, Albert J Czaja, Aldo J Montano-Loza
Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis. Alimentary pharmacology & therapeutics 49 (2) (2018)
Albert J Czaja
Review article: next-generation transformative advances in the pathogenesis and management of autoimmune hepatitis. Alimentary pharmacology & therapeutics 46 (10) (2017)

Albert J Czaja (A J Czaja)

Publication Activity (10 Years)

Top Topics

Top Venues